US4961931A
(en)
*
|
1982-07-29 |
1990-10-09 |
Alza Corporation |
Method for the management of hyperplasia
|
US5208225A
(en)
*
|
1986-02-27 |
1993-05-04 |
Warner-Lambert Company |
Compositions containing fixed combinations
|
DK174724B1
(da)
*
|
1986-07-15 |
2003-10-06 |
Wyeth Corp |
Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
|
CH674618A5
(de)
*
|
1987-04-02 |
1990-06-29 |
Ciba Geigy Ag |
|
ATE66149T1
(de)
*
|
1987-07-06 |
1991-08-15 |
Akzo Nv |
Pharmazeutische dosierungseinheit zur vorbeugung bzw. behandlung von klimakterischen beschwerden.
|
US4900734A
(en)
*
|
1987-08-27 |
1990-02-13 |
Maxson Wayne S |
Novel pharmaceutical composition containing estradiol and progesterone for oral administration
|
US5108995A
(en)
*
|
1987-09-24 |
1992-04-28 |
Jencap Research Ltd. |
Hormone preparation and method
|
US5276022A
(en)
*
|
1987-09-24 |
1994-01-04 |
Jencap Research Ltd. |
Hormone preparation and method
|
EP0322020A1
(de)
*
|
1987-12-22 |
1989-06-28 |
Akzo N.V. |
Pharmazeutische Dosierungseinheit zur Behandlung von klimakterischen Beschwerden und Osteoporosis
|
HUT52382A
(en)
*
|
1988-03-14 |
1990-07-28 |
Sandoz Ag |
Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
|
GB8813353D0
(en)
*
|
1988-06-06 |
1988-07-13 |
Ici Plc |
Therapeutic product
|
PH30747A
(en)
*
|
1989-03-10 |
1997-10-17 |
Endorech Inc |
Combination therapy for the treatment of estrogen sensitive disease.
|
US5043331A
(en)
*
|
1989-06-15 |
1991-08-27 |
Orion-Yhtyma Oy |
Treatment of postmenopausal disorders
|
HU222501B1
(hu)
*
|
1991-06-28 |
2003-07-28 |
Endorecherche Inc. |
MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
|
ZA924811B
(en)
*
|
1991-06-28 |
1993-12-29 |
Endorecherche Inc |
Controlled release systems and low dose androgens
|
IL107343A
(en)
*
|
1992-11-02 |
2003-10-31 |
Wyeth Corp |
PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD LIPID LEVEL, COMPRISING, 17alpha-DIHYDROEQUILENIN
|
US6037339A
(en)
|
1993-02-08 |
2000-03-14 |
Akzo Nobel N.V. |
C-11 substituted steroids for treating menopausal complaints
|
US5710144A
(en)
*
|
1993-02-08 |
1998-01-20 |
Akzo Nobel N.V. |
C-11 substituted steroids for treating menopausal complaints
|
ZA94715B
(en)
*
|
1993-02-08 |
1994-10-24 |
Akzo Nv |
Steroids for treating menopausal complaints
|
DE4344462C2
(de)
|
1993-12-22 |
1996-02-01 |
Schering Ag |
Zusammensetzung für die Empfängnisverhütung
|
US5547948A
(en)
*
|
1995-01-17 |
1996-08-20 |
American Home Products Corporation |
Controlled release of steroids from sugar coatings
|
US5759577A
(en)
*
|
1995-01-17 |
1998-06-02 |
American Home Products Corporation |
Controlled release of steroids from sugar coatings
|
DE19510861A1
(de)
*
|
1995-03-16 |
1996-09-19 |
Schering Ag |
Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen
|
US5861431A
(en)
*
|
1995-06-07 |
1999-01-19 |
Iotek, Inc. |
Incontinence treatment
|
WO1997004752A1
(en)
*
|
1995-07-26 |
1997-02-13 |
Duramed Pharmaceuticals, Inc. |
Pharmaceutical compositions of conjugated estrogens and methods for their use
|
FR2737411B1
(fr)
*
|
1995-08-01 |
1997-10-17 |
Theramex |
Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
|
US5654011A
(en)
*
|
1996-07-30 |
1997-08-05 |
Energetics, Inc. |
Dietary supplements
|
US5807586A
(en)
*
|
1996-07-30 |
1998-09-15 |
Energetics, Inc. |
Method of dietary supplementation
|
US6040333A
(en)
*
|
1996-07-30 |
2000-03-21 |
Energetics, Inc. |
Dietary supplements
|
FR2754179B1
(fr)
*
|
1996-10-08 |
1998-12-24 |
Theramex |
Nouvelle composition hormononale et son utilisation
|
US5898032A
(en)
|
1997-06-23 |
1999-04-27 |
Medical College Of Hampton Roads |
Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
|
DE19739916C2
(de)
|
1997-09-11 |
2001-09-13 |
Hesch Rolf Dieter |
Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
|
EP1098653A2
(de)
*
|
1998-07-17 |
2001-05-16 |
PHARMACIA & UPJOHN COMPANY |
Subkutane verabreichung von medroxyprogesteronacetat zur kontrazeption
|
US6165504A
(en)
*
|
1998-09-23 |
2000-12-26 |
Barr Laboratories, Inc. |
Methods for treating hot flashes and improving the quality of life of castrated prostatic cancer patients
|
CA2311937A1
(en)
*
|
1998-10-09 |
2000-04-20 |
Pharmacia & Upjohn Company Llc |
Subcutaneous medroxyprogesterone acetate for treatment of menopause and endometriosis
|
US6613758B1
(en)
|
1999-04-02 |
2003-09-02 |
Barr Laboratories, Inc. |
Method for treating osteoporosis in castrated prostatic cancer patients
|
US6703367B1
(en)
|
1999-04-27 |
2004-03-09 |
Praecis Pharmaceuticals Inc. |
Methods for treating hot flashes and gynaecomastia
|
US6787531B1
(en)
*
|
1999-08-31 |
2004-09-07 |
Schering Ag |
Pharmaceutical composition for use as a contraceptive
|
WO2001030356A1
(fr)
*
|
1999-10-25 |
2001-05-03 |
Laboratoire Theramex |
Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
|
US20020132801A1
(en)
*
|
2001-01-11 |
2002-09-19 |
Schering Aktiengesellschaft |
Drospirenone for hormone replacement therapy
|
US7025979B2
(en)
|
2000-02-15 |
2006-04-11 |
Schering Ag |
Male contraceptive formulation comprising norethisterone
|
US6660726B2
(en)
*
|
2000-03-10 |
2003-12-09 |
Endeavor Pharmaceuticals |
Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
|
US7459445B2
(en)
*
|
2000-03-10 |
2008-12-02 |
Duramed Pharmaceuticals, Inc. |
Estrogenic compounds and topical pharmaceutical formulations of the same
|
US7989436B2
(en)
|
2003-07-23 |
2011-08-02 |
Duramed Pharmaceuticals, Inc. |
Estrogenic compounds and pharmaceutical formulations comprising the same
|
US6855703B1
(en)
|
2000-03-10 |
2005-02-15 |
Endeavor Pharmaceuticals |
Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
|
US20010034340A1
(en)
*
|
2000-03-20 |
2001-10-25 |
American Home Products Corporation |
Hormone replacement therapy
|
US20020151530A1
(en)
*
|
2000-12-22 |
2002-10-17 |
Leonard Thomas W. |
Method of treating hormonal deficiencies in women undergoing estrogen replacement therapy
|
DE10100911A1
(de)
*
|
2001-01-11 |
2002-08-01 |
Schering Ag |
Verfahren zur Hormonersatztherapie und dessen Darreichungsform
|
US20060142257A1
(en)
*
|
2001-01-19 |
2006-06-29 |
Eberhard Nieschlag |
Male contraceptive formulation comprising norethisterone
|
JP2004524354A
(ja)
*
|
2001-03-16 |
2004-08-12 |
ワイス |
エストロゲン補充療法
|
IL157944A0
(en)
*
|
2001-03-16 |
2004-03-28 |
Wyeth Corp |
Hormone replacement therapy
|
FR2823976A1
(fr)
*
|
2001-04-25 |
2002-10-31 |
Theramex |
Nouvelle composition hormonale et son utilisation
|
US20130203722A1
(en)
|
2006-09-26 |
2013-08-08 |
Rhonda R. Voskuhl |
Estriol therapy for autoimmune and neurodegenerative disease and disorders
|
WO2002092102A2
(en)
|
2001-05-16 |
2002-11-21 |
Endeavor Pharmaceuticals |
Treatment of conditions relating to hormone deficiencies by administration of progestins
|
WO2003006027A1
(en)
*
|
2001-07-13 |
2003-01-23 |
Schering Aktiengesellschaft |
Combination of drospirenone and an estrogen sulphamate for hrt
|
WO2003018026A1
(en)
*
|
2001-08-31 |
2003-03-06 |
Pantarhei Bioscience B.V. |
Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
|
PT1453521E
(pt)
|
2001-12-05 |
2013-10-08 |
Teva Womens Health Inc |
Contracetivos orais para prevenir a gravidez e diminuir a sintomatologia pré-menstrual
|
US20030216366A1
(en)
*
|
2002-04-03 |
2003-11-20 |
Leonard Thomas W. |
Step-down estrogen therapy
|
US20030191096A1
(en)
*
|
2002-04-03 |
2003-10-09 |
Leonard Thomas W. |
Method of hormonal therapy
|
TW200306851A
(en)
*
|
2002-04-29 |
2003-12-01 |
Wyeth Corp |
Hormone replacement therapy
|
TW200400040A
(en)
*
|
2002-05-17 |
2004-01-01 |
Wyeth Corp |
Hormone replacement therapy
|
TW200404551A
(en)
*
|
2002-05-17 |
2004-04-01 |
Wyeth Corp |
Hormone replacement therapy
|
RU2340345C2
(ru)
*
|
2002-08-28 |
2008-12-10 |
Роберт КАСПЕР |
Схема восполнения эстрогена
|
EP1462106A1
(de)
*
|
2003-03-28 |
2004-09-29 |
Pantarhei Bioscience B.V. |
Pharmazeutishe Zusammensetzungen und Kits enthaltend 17-Betaestradiol und Progesteron zur Behandlung von Gynäcologischen Storungen
|
US6992075B2
(en)
*
|
2003-04-04 |
2006-01-31 |
Barr Laboratories, Inc. |
C(14) estrogenic compounds
|
CA2521471A1
(en)
*
|
2003-04-11 |
2004-10-28 |
Barr Laboratories, Inc. |
Methods of administering estrogens and progestins
|
WO2004098517A2
(en)
*
|
2003-05-02 |
2004-11-18 |
Duramed Pharmaceuticals, Inc. |
Methods of hormonal treatment utilizing extended cycle contraceptive regimens
|
CA2771944A1
(en)
*
|
2003-07-16 |
2005-01-27 |
Teva Women's Health, Inc. |
Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
|
AU2004275470B2
(en)
*
|
2003-09-29 |
2010-12-02 |
Novo Nordisk Health Care Ag |
Improved stability of progestogen formulations
|
PT1670440E
(pt)
*
|
2003-09-29 |
2014-08-22 |
Novo Nordisk Femcare Ag |
Formulações hrt
|
CA2566811A1
(en)
*
|
2004-05-26 |
2005-12-15 |
Wyeth |
Compositions and methods for treatment of premenstrual dysphoric disorder
|
DE102004026669A1
(de)
*
|
2004-05-28 |
2005-12-15 |
Grünenthal GmbH |
Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels
|
DE102004026679A1
(de)
|
2004-05-28 |
2005-12-15 |
Grünenthal GmbH |
Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
|
US20060040904A1
(en)
*
|
2004-08-17 |
2006-02-23 |
Ahmed Salah U |
Vaginal cream compositions, kits thereof and methods of using thereof
|
US20070111975A1
(en)
|
2004-10-07 |
2007-05-17 |
Duramed Pharmaceuticals, Inc. |
Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
|
EP1853272A1
(de)
*
|
2005-02-03 |
2007-11-14 |
Duramed Pharmaceuticals, Inc. |
Zusammensetzungen aus unkonjugierten östrogenen und anwendungsverfahren dafür
|
JP2009521533A
(ja)
*
|
2005-12-27 |
2009-06-04 |
デュラメド ファーマシューティカルズ インコーポレーティッド |
結合型エストロゲン組成物、アプリケーター、キット、ならびにそれらの作製および使用の方法
|
AR065816A1
(es)
*
|
2007-03-26 |
2009-07-01 |
Theramex |
Regimen anticonceptivo oral
|
EP2164498A4
(de)
|
2007-06-04 |
2010-09-08 |
Univ California |
Schwangerschaftshormonkombination zur behandlung von autoimmunkrankheiten
|
CA2795801C
(en)
|
2010-04-15 |
2018-05-29 |
Bayer Intellectual Property Gmbh |
Very low-dosed solid oral dosage forms for hrt
|
HUE055562T2
(hu)
|
2011-11-23 |
2021-11-29 |
Therapeuticsmd Inc |
Természetes kombinációjú hormon helyettesítõ kiszerelések, és terápiák ezekkel
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
EP3137088B1
(de)
|
2014-04-28 |
2023-08-30 |
The Regents of The University of California |
Pharmazeutische verpackung für estrioltherapie zur behandlung von multipler sklerose
|
EP3137087B1
(de)
|
2014-04-28 |
2023-09-06 |
The Regents of the University of California |
Östrogenkombination zur behandlung von multipler sklerose
|
RU2016143081A
(ru)
|
2014-05-22 |
2018-06-26 |
Терапьютиксмд, Инк. |
Натуральные комбинированные гормонозаместительные составы и терапии
|
WO2016036719A1
(en)
|
2014-09-02 |
2016-03-10 |
The Regents Of The University Of California |
Estrogen therapy for brain gray matter atrophy and associated disability
|
ES2957543T3
(es)
|
2014-09-29 |
2024-01-22 |
Univ California |
Composiciones y métodos para mantener la función cognitiva
|
WO2016160832A1
(en)
|
2015-03-30 |
2016-10-06 |
The Regents Of The University Of California |
Methods of monitoring estriol therapy
|
EA035687B1
(ru)
|
2015-06-18 |
2020-07-27 |
Эстетра Спрл |
Диспергируемая в полости рта единица дозирования, содержащая эстетрольный компонент
|
UA123098C2
(uk)
|
2015-06-18 |
2021-02-17 |
Естетра Спрл |
Диспергована у порожнині рота одиниця дозування, що містить естетрольний компонент
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
KR20180126582A
(ko)
|
2016-04-01 |
2018-11-27 |
쎄러퓨틱스엠디, 인코퍼레이티드 |
스테로이드 호르몬 약제학적 조성물
|
CA3178291A1
(en)
|
2016-08-05 |
2018-04-12 |
Estetra Srl |
Method for the management of dysmenorrhea and menstrual pain
|
JOP20200260A1
(ar)
|
2018-04-19 |
2019-10-19 |
Estetra Sprl |
مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
|
TWI801561B
(zh)
|
2018-04-19 |
2023-05-11 |
比利時商依思特拉私人有限責任公司 |
化合物及其用於緩解絕經相關症狀的用途
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|